Chronic Myelomonocytic Leukemia Market Driven by Targeted Therapies

added blog Health

2025-05-05 11:06:07 -

The Chronic Myelomonocytic Leukemia (CMML) market encompasses a suite of diagnostic assays, hypomethylating agents, targeted small molecules, and supportive care products designed to address the rare blood malignancy characterized by monocytic proliferation. Leading therapies such as azacitidine and decitabine offer epigenetic modulation to inhibit malignant clone growth, while emerging...

0 Comments 0 Shares 155 Views 0 Reviews